The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(5S,E)-tert-butyl 5-benzyl-3-(1-hydroxy-3-methylbutylidene)-2,4-dioxopyrrolidine-1-carboxylate ID: ALA4549755
PubChem CID: 155550812
Max Phase: Preclinical
Molecular Formula: C21H27NO5
Molecular Weight: 373.45
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)C/C(O)=C1/C(=O)[C@H](Cc2ccccc2)N(C(=O)OC(C)(C)C)C1=O
Standard InChI: InChI=1S/C21H27NO5/c1-13(2)11-16(23)17-18(24)15(12-14-9-7-6-8-10-14)22(19(17)25)20(26)27-21(3,4)5/h6-10,13,15,23H,11-12H2,1-5H3/b17-16+/t15-/m0/s1
Standard InChI Key: GITBLIOWSNDYJO-MWWIPNPYSA-N
Molfile:
RDKit 2D
27 28 0 0 0 0 0 0 0 0999 V2000
39.9474 -26.0924 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.7646 -26.0924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.0190 -25.3157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.3560 -24.8335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6973 -25.3157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.4662 -26.7529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9200 -25.0635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.3548 -24.0163 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
41.7965 -25.0642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.2442 -26.7541 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
42.4030 -25.6119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.9675 -24.2651 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.7497 -24.2642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.7976 -27.4998 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.6536 -26.6664 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.1724 -27.3269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3598 -27.2404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5038 -28.0739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.7559 -28.0321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.3586 -23.7180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.1889 -22.9194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.4109 -22.6666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8024 -23.2184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9753 -24.0150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.1806 -25.3604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.7871 -25.9081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.3516 -24.5613 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 1 0
1 6 1 0
5 7 1 1
4 8 2 0
3 9 2 0
2 10 2 0
9 11 1 0
9 12 1 0
7 13 1 0
6 14 2 0
6 15 1 0
15 16 1 0
16 17 1 0
16 18 1 0
16 19 1 0
13 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 13 1 0
11 25 1 0
25 26 1 0
25 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 373.45Molecular Weight (Monoisotopic): 373.1889AlogP: 3.80#Rotatable Bonds: 4Polar Surface Area: 83.91Molecular Species: ACIDHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 4.95CX Basic pKa: ┄CX LogP: 4.19CX LogD: 1.77Aromatic Rings: 1Heavy Atoms: 27QED Weighted: 0.49Np Likeness Score: 0.37
References 1. de Souza AS, Pacheco BDC, Pinheiro S, Muri EMF, Dias LRS, Lima CHS, Garrett R, de Moraes MBM, de Souza BEG, Puzer L.. (2019) 3-Acyltetramic acids as a novel class of inhibitors for human kallikreins 5 and 7., 29 (9): [PMID:30833107 ] [10.1016/j.bmcl.2019.02.031 ]